Timepoints

Name	REDCap Event Name	Description
Hospital Discharge	hospital_discharge_arm_1	Data relevant to the index admission where the discharge diagnosis was a confirmed or a suspected illness caused by COVID-19 (CRF1).
6 Weeks	6_weeks_arm_1	Telephone contact with participant which has occurred as part of routine COVID-19 related follow-up approximately 6 weeks post-discharge (CRF2).
3 Months (1st Research Visit)	3_months_1st_resea_arm_1	3 months' follow-up time window is 2-7 months +/-2 weeks post-discharge. For all participants, this will contain COVID-related clinical visit which falls within the 3 months follow-up time window (CRF3A). For Tier 2 participants, this will contain data from the first research visit (CRF3B; CRF3C)
Add. Planned Clinical Visits	add_planned_clinic_arm_1	Data from any additional planned COVID-19 clinical follow-up that falls outside of the 3 month and 12 month time windows.
12 Months (2nd Research Visit)	12_months_2nd_rese_arm_1	12 months' follow-up time window is 10-14 months post-discharge. For all participants, this will contain COVID-related clinical visit which falls within the 12 months follow-up time window (CRF3A). For Tier 2 participants, this will contain data from the second research visit (CRF3B; CRF3C)
Unscheduled	unscheduled_arm_1	Data from emergency visits attended acutely at hospital for any urgent need during the 12 months post-discharge - this could include attending Accident and Emergency (A&E) department, review in a medical admission unit or ambulatory care or a hospital admission regardless of the duration. Documentation of Adverse Events (AEs) that occur as a result of any research procedure and participant withdrawal from the PHOSP-COVID study.